Evaluation of the “safe multidisciplinary app-assisted remote patient-self-testing (SMART) model” for warfarin home management during the COVID-19 pandemic: study protocol of a multi-center randomized controlled trial

BACKGROUND: Warfarin treatment requires frequent monitoring of INR (international normalized ratio) to adjust dosage in a therapeutic range. In China, patients living in small towns usually go to tertiary hospitals to get warfarin monitoring and dosing, resulting in low frequencies of follow-ups and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lei, Zhou, Yang-Zhao, Zhou, Xin-Min, Liu, Li-Ming, Xu, Ping, Zhang, Xia, Tan, Sheng-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390025/
https://www.ncbi.nlm.nih.gov/pubmed/34445995
http://dx.doi.org/10.1186/s12913-021-06882-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390025/
https://www.ncbi.nlm.nih.gov/pubmed/34445995
http://dx.doi.org/10.1186/s12913-021-06882-7

Ejemplares similares